<DOC>
	<DOCNO>NCT01377168</DOCNO>
	<brief_summary>This study recruit 159 HIV-infected men alcohol use disorder ( AUDs ) . Men randomize receive either oral naltrexone treatment alcohol use disorder placebo . Men acute , recent establish HIV infection receive antiretroviral treatment ( ART ) randomize oral naltrexone placebo . The purpose study see whether use oral naltrexone improve medication compliance , therefore HIV viral load suppression , among men alcohol use disorder . The study also assess impact oral naltrexone alcohol use behavior population .</brief_summary>
	<brief_title>Naltrexone Medication Compliance Among HIV-infected Men With Alcohol Use Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Meets DSMIV criterion alcohol dependence problem drinking . Age 18 year old Confirmed HIV infection , either positive HIV antibody detectable HIV1 RNA level . No participation pharmacotherapy trial previous 30 day Not pregnant Unable provide inform consent Verbally physically threaten research staff Unable communicate Spanish Pending trial felony ChildsPugh Class C Cirrhosis Grade 3 Hepatitis ( LFTs &gt; 5X normal ) Receiving opioid prescription narcotic pain syndrome necessitating future use opioid prescription narcotic .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>